May 17, 2016
Via: Mass DeviceMitralign said today that it raised a Series E round worth nearly $40 million for a pair of heart valve repair devices, its namesake Mitralign annuloplasty system and the Trialign device for tricuspid repair. The Tewksbury, Mass.-based company said it plans to […]
July 9, 2024
June 25, 2024